Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Takeda drops prostate cancer drug in phase III

Takeda drops prostate cancer drug in phase III Zytiga (abiraterone acetate), which brought in revenues of $1.7bn last year, and Astellas/Medivation's fast-growing Xtandi (enzalutamide) which pulled in almost $400m last year.  . ... A recent report by Decision Resources suggested Zytiga and Xtandi

Oncology drugs under AMNOG: part two

Oncology drugs under AMNOG: part two It is important to separate observable patient-relevant outcomes from surrogate measures based on biomarker analysis or pathological assessment, even though these may overlap: for example, in the case of

Back to the future

Back to the future Likewise, J&J had a strong year - with eight of its key products, including Zytiga, Xarelto, Remicade, Stelara and Invega Sustenna/Xeplion, driving collective growth of more than $3.5bn (10

NICE won't back early use of Zytiga in prostate cancer

NICE won't back early use of Zytiga in prostate cancer Says Janssen drug should not be used prior to chemotherapy. Janssen's Zytiga should remain as a second-line therapy after chemotherapy in England and Wales, according to new recommendations from ... In its response, Janssen criticised NICE's decision not

NICE backtracks on prostate cancer drug enzalutamide

NICE backtracks on prostate cancer drug enzalutamide Janssen's rival oncology product Zytiga (abiraterone). .

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....